Sionna Therapeutics, Inc. (SION) Stock Forecast & Price Target

Compare

23 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SION Analyst Ratings

Moderate Buy

4 Buy

0 Hold

1 Sell

Based on 5 analysts giving stock ratings to

Sionna

Therapeutics, Inc.

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SION Stock 12 Month Forecast

Average Price Target

$42.75

▲(0.90% Upside)

Based on 5 Wall Street analysts offering 12 month price targets for Sionna Therapeutics, Inc. in the last 3 months. The average price target is $42.75 with a high forecast of $52.00 and a low forecast of $24.00. The average price target represents a 0.90% change from the last price of $42.37.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"9":"$9","20":"$20","31":"$31","42":"$42","53":"$53"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":52,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$52.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":42.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$42.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$24.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[9,20,31,42,53],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"Apr<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,38.96,39.963076923076926,40.966153846153844,41.96923076923077,42.972307692307695,43.97538461538461,44.97846153846154,45.98153846153846,46.98461538461538,47.987692307692306,48.99076923076923,49.99384615384615,50.996923076923075,{"y":52,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,38.96,39.25153846153846,39.543076923076924,39.83461538461538,40.12615384615385,40.417692307692306,40.70923076923077,41.00076923076923,41.292307692307695,41.58384615384615,41.87538461538462,42.16692307692308,42.458461538461535,{"y":42.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,38.96,37.80923076923077,36.65846153846154,35.50769230769231,34.35692307692308,33.206153846153846,32.05538461538462,30.904615384615386,29.753846153846155,28.603076923076923,27.45230769230769,26.301538461538463,25.15076923076923,{"y":24,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.24,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.24,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.24,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.24,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":13.77,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":13.77,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.16,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.92,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.39,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.47,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.21,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.96,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$52.00

Average Price Target$42.75

Lowest Price Target$24.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Debanjana Chatterjee

JonesTrading

$52

Buy

22.73%

Upside

Reiterated

12/15/25

Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (NASDAQ: SION) and Novan (NASDAQ: NOVN)

Brian Abrahams

RBC Capital

$24

Sell

-43.36%

Downside

Reiterated

12/04/25

RBC Capital Sticks to Their Sell Rating for Sionna Therapeutics, Inc. (SION)

Unknown Analyst

BTIG

Not Ranked

BTIG

$50

Buy

18.01%

Upside

Reiterated

12/02/25

BTIG Remains a Buy on Sionna Therapeutics, Inc. (SION)

Unknown Analyst

BTIG

Not Ranked

BTIG

$50

Buy

18.01%

Upside

Initiated

11/19/25

BTIG Assigns Buy Rating to Sionna Therapeutics, Citing Innovative Cystic Fibrosis Therapies and Strong Market Potential

Ritu Baral

TD Cowen

Buy

―

Reiterated

11/05/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sionna Therapeutics, Inc. (NASDAQ: SION) and Arvinas Holding Company (NASDAQ: ARVN)

Unknown Analyst

Raymond James

Not Ranked

Raymond James

$30.91→$45

Buy

6.21%

Upside

Reiterated

10/16/25

Sionna Therapeutics, Inc. (SION) Gets a Buy from Raymond James

Yatin Suneja

Guggenheim

$45

Buy

6.21%

Upside

Reiterated

08/11/25

Guggenheim Keeps Their Buy Rating on Sionna Therapeutics, Inc. (SION)

Paul Matteis

Stifel Nicolaus

$32

Buy

-24.47%

Downside

Reiterated

05/14/25

Analysts Offer Insights on Healthcare Companies: Cencora (NYSE: COR), Sionna Therapeutics, Inc. (NASDAQ: SION) and Astria Therapeutics (NASDAQ: ATXS)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Debanjana Chatterjee

JonesTrading

$52

Buy

22.73%

Upside

Reiterated

12/15/25

Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (NASDAQ: SION) and Novan (NASDAQ: NOVN)

Brian Abrahams

RBC Capital

$24

Sell

-43.36%

Downside

Reiterated

12/04/25

RBC Capital Sticks to Their Sell Rating for Sionna Therapeutics, Inc. (SION)

Unknown Analyst

BTIG

Not Ranked

BTIG

$50

Buy

18.01%

Upside

Reiterated

12/02/25

BTIG Remains a Buy on Sionna Therapeutics, Inc. (SION)

Unknown Analyst

BTIG

Not Ranked

BTIG

$50

Buy

18.01%

Upside

Initiated

11/19/25

BTIG Assigns Buy Rating to Sionna Therapeutics, Citing Innovative Cystic Fibrosis Therapies and Strong Market Potential

Ritu Baral

TD Cowen

Buy

―

Reiterated

11/05/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sionna Therapeutics, Inc. (NASDAQ: SION) and Arvinas Holding Company (NASDAQ: ARVN)

Unknown Analyst

Raymond James

Not Ranked

Raymond James

$30.91→$45

Buy

6.21%

Upside

Reiterated

10/16/25

Sionna Therapeutics, Inc. (SION) Gets a Buy from Raymond James

Yatin Suneja

Guggenheim

$45

Buy

6.21%

Upside

Reiterated

08/11/25

Guggenheim Keeps Their Buy Rating on Sionna Therapeutics, Inc. (SION)

Paul Matteis

Stifel Nicolaus

$32

Buy

-24.47%

Downside

Reiterated

05/14/25

Analysts Offer Insights on Healthcare Companies: Cencora (NYSE: COR), Sionna Therapeutics, Inc. (NASDAQ: SION) and Astria Therapeutics (NASDAQ: ATXS)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sionna Therapeutics, Inc.

1 Month

xxx

Success Rate

3/3 ratings generated profit

Average Return

+16.07%

reiterated a xxx

rating 6 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +16.07% per trade.

3 Months

xxx

Success Rate

5/5 ratings generated profit

Average Return

+51.22%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +51.22% per trade.

1 Year

Paul MatteisStifel Nicolaus

Success Rate

2/2 ratings generated profit

Average Return

+233.55%

reiterated a buy rating 7 months ago

Copying Paul Matteis's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +233.55% per trade.

2 Years

xxx

Success Rate

2/2 ratings generated profit

Average Return

+233.55%

reiterated a xxx

rating 7 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +233.55% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SION Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SION has received 7 Buy Ratings, 1 Hold Ratings, and 2 Sell Ratings. SION average Analyst price target in the past 3 months is 42.75.

Each month's total comprises the sum of three months' worth of ratings.

SION Financial Forecast

SION Earnings Forecast

Next quarter’s earnings estimate for SION is -$0.54 with a range of -$0.71 to -$0.45. The previous quarter’s EPS was -$0.46. SION beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year SION has Performed in-line its overall industry.

No data currently available

SION Sales Forecast

Next quarter’s sales forecast for SION is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. SION beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year SION has Performed in-line its overall industry.

SION Stock Forecast FAQ

What is SION’s average 12-month price target, according to analysts?

Based on analyst ratings, Sionna Therapeutics, Inc.’s 12-month average price target is 42.75.

What is SION’s upside potential, based on the analysts’ average price target?

Sionna Therapeutics, Inc. has 0.90% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is SION a Buy, Sell or Hold?

Sionna Therapeutics, Inc. has a consensus rating of Moderate Buy which is based on 4 buy ratings, 0 hold ratings and 1 sell ratings.

What is Sionna Therapeutics, Inc.’s price target?

The average price target for Sionna Therapeutics, Inc. is 42.75. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $52.00 ,the lowest forecast is $24.00. The average price target represents 0.90% Increase from the current price of $42.37.

What do analysts say about Sionna Therapeutics, Inc.?

Sionna Therapeutics, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 5 Wall Streets Analysts.

How can I buy shares of SION?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Sionna Therapeutics, Inc. (SION) Stock Forecast & Price Target

SION Analyst Ratings

SION Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Sionna Therapeutics, Inc.

SION Analyst Recommendation Trends

SION Financial Forecast

SION Earnings Forecast

SION Sales Forecast

SION Stock Forecast FAQ

Detailed List of Analyst Forecasts